INTERNATIONAL PATENT: CHANGCHUN GENESCIENCE PHARMACEUTICAL CO., LTD., 长春金赛药业有限责任公司 FILES APPLICATION FOR "ANTI-PD-1 MONOCLONAL ANTIBODY AND USE THEREOF"

GENEVA, April 18 -- CHANGCHUN GENESCIENCE PHARMACEUTICAL CO., LTD. (1718 Yueda Road, Changchun High-Tech Dev. ZoneChangchun, Jilin 130012), 长春金赛药业有限责任公司 (中国吉林省长春市高新区越达路1718号) filed a patent application (PCT/CN2024/123741) for "ANTI-PD-1 MONOCLONAL ANTIBODY AND USE THEREOF" on Oct 09, 2024. With publication no. WO/2025/077741, the details related to the patent application was published on Apr 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Proper...